Christopher R. Flowers, MD, on Disparities in Lymphoma and Myeloma
The lymphoma and myeloma expert indicated that one of the key ways to address these disparities in lymphoma and myeloma is to improve minority and rural accrual in clinical trials. (Source: CancerNetwork)
Source: CancerNetwork - May 21, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Expert Discusses Home Treatment for Aggressive Lymphomas Amidst COVID-19 Pandemic
Stephen Schuster, MD, explained how Penn Medicine is utilizing at-home treatments, which will continue after the pandemic, to maximize safety and reduce hospital traffic during the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - May 20, 2020 Category: Cancer & Oncology Authors: Stephen Schuster, MD Source Type: news
FDA Approves Olaparib for HRR Gene-Mutated mCRPC
The FDA approved olaparib for the treatment of adult patients with deleterious or suspected deleterious germline or somatic homologous recombination repair gene-mutated metastatic castration-resistant prostate cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 20, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Changes to Global Oncology Trial Management Due to COVID-19
Researchers highlighted the current challenges, risks, and future implications for global oncology trial management as a result of the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - May 20, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Combination of Durvalumab and Tremelimumab May Prolong OS in CRC
This phase II trial suggested that combination immune checkpoint inhibition with durvalumab plus tremelimumab may be associated with prolonged overall survival in patients with advanced refractory colorectal cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 20, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Tivozanib Induces Durable Response Among Patients with Advanced Renal Cell Carcinoma
The VEGF TKI induced durable responses and favorable tolerability in patients with relapsed/refractory RCC. (Source: CancerNetwork)
Source: CancerNetwork - May 20, 2020 Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news
Palliative Care for Patients with Cancer During the COVID-19 Pandemic
Ambereen K. Mehta, MD, MPH, and Thomas J. Smith, MD, highlighted the necessity for palliative care services for patients with cancer to continue amidst the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - May 19, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Text-Messaging Interventions Did Not Reduce Aromatase Inhibitor Adherence Failure
This study found that a biweekly unidirectional text-messaging intervention did not reduce aromatase inhibitor adherence failure in women with breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 19, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Angela R. Bradbury, MD, on Telemedicine in Genetic Counseling
The associate professor of Medicine spoke about the use of of telemedicine in genetic counseling before the COVID-19 pandemic, how it is used today, and how telemedicine may be utilized in this space moving forward. (Source: CancerNetwork)
Source: CancerNetwork - May 19, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Assessment of Sarcopenia Measures Reveals Accelerated Loss in Older Adults with Cancer
A recent examination of older adults with cancer found accelerated losses in differing sarcopenia measures existed before and after a cancer diagnosis. (Source: CancerNetwork)
Source: CancerNetwork - May 19, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
Saad Z. Usmani, on the Approval of Daratumumab and Hyaluronidase-fihj
The hematologist and medical oncologist discussed the approval of daratumumab and hyaluronidase-fihj for use in adult patients with newly diagnosed or relapsed/refractory multiple myeloma. (Source: CancerNetwork)
Source: CancerNetwork - May 18, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
SARS-CoV-2 Infection in Pediatric Patients with Cancer
This study indicated that pediatric patients with cancer may not be more vulnerable than other children to infection or morbidity resulting from SARS-CoV-2. (Source: CancerNetwork)
Source: CancerNetwork - May 18, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Watching Disney Movies During Chemo May Improve QoL in Patients with Gynecologic Cancer
Recent findings suggested that watching Disney movies during chemotherapy treatment may be correlated with improvements in quality of life in patients with gynecologic cancers. (Source: CancerNetwork)
Source: CancerNetwork - May 18, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Dexrazoxane Preserved Cardiac Function in Children Undergoing Chemotherapy for AML
A study found that dexrazoxane, a cardioprotective drug, preserved cardiac function without compromising overall survival and event-free survival for pediatric patients with acute myeloid leukemia. (Source: CancerNetwork)
Source: CancerNetwork - May 18, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
FDA Approves Atezolizumab as a First-Line Treatment for Metastatic NSCLC Subgroup
Atezolizumab was approved as a first-line treatment for adults with metastatic non-small cell lung cancer whose tumors have high PD-L1 expression, as determined by an FDA approved test, with no EGFR or ALK genomic tumor aberrations. (Source: CancerNetwork)
Source: CancerNetwork - May 18, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
